Grantham, Mayo, Van Otterloo & Co (GMO)’s Himax Technologies HIMX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HIMX Stock Details HIMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-228,900	Closed	-$2.09M	–	604
2017 Q1	$2.09M	Sell	228,900 -137,900	-38%	-$934K	0.01%	320
2016 Q4	$2.21M	Buy	366,800 +10,800	+3%	+$81.6K	0.01%	307
2016 Q3	$3.06M	Sell	356,000 -74,200	-17%	-$695K	0.01%	295
2016 Q2	$3.55M	Sell	430,200 -150,000	-26%	-$1.48M	0.01%	326
2016 Q1	$6.52M	Sell	580,200 -180,800	-24%	-$1.59M	0.02%	276
2015 Q4	$6.24M	Buy	761,000 +555,200	+270%	+$4.02M	0.02%	231
2015 Q3	$1.64M	Buy	205,800 +38,400	+23%	+$285K	0.01%	350
2015 Q2	$1.34M	Buy	+167,400	New	+$1.14M	﹤0.01%	345
2013 Q4	–	Sell	-13,900	Closed	-$139K	–	681
2013 Q3	$139K	Buy	+13,900	New	+$98.8K	﹤0.01%	651

Other funds holding HIMX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KIP

Kayak Investment Partners San Francisco, California $52.5M AUM 39.54% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PSCM

Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return

QAM

Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return

Dalton Investments Las Vegas, Nevada $111M AUM 7.89% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HIMX Position: Q2 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Himax Technologies (HIMX) in Q2 2017, closing a stake of 228,900 shares — an estimated $2.09M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HIMX in Q3 2013 and held it in 9 quarters. The position peaked at $6.52M in Q1 2016. 101 funds tracked by Wall St. Rank hold HIMX as of Q2 2017.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Himax Technologies position as of Q2 2017 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 228,900 Himax Technologies shares in Q2 2017, an estimated $2.09M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Himax Technologies in Q3 2013 and held it in 9 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Himax Technologies position peaked at $6.52M in Q1 2016.
101 funds tracked by Wall St. Rank held Himax Technologies as of Q2 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2017, filed 14 Aug 2017.